Literature DB >> 20447490

Infection and colonization in epidermolysis bullosa.

Jemima E Mellerio1.   

Abstract

In all forms of epidermolysis bullosa (EB), skin fragility may result in bacterial colonization or infection, particularly in the more severe forms where wounds may be multiple and long-standing. A balance exists between a wound's bacterial load and the host defenses, such that there is a spectrum from simple contamination, through colonization, critical colonization, to overt infection. The increased bioburden in critically colonized or infected wounds impairs healing and therefore recognition of these situations, and appropriate measures to promote a healing environment, are fundamental to the care of EB wounds. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447490     DOI: 10.1016/j.det.2010.01.004

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  13 in total

1.  A consensus approach to wound care in epidermolysis bullosa.

Authors:  Elena Pope; Irene Lara-Corrales; Jemima Mellerio; Anna Martinez; Gregory Schultz; Robert Burrell; Laurie Goodman; Patricia Coutts; John Wagner; Upton Allen; Gary Sibbald
Journal:  J Am Acad Dermatol       Date:  2012-03-02       Impact factor: 11.527

Review 2.  [Mucosal manifestations of epidermolysis bullosa : Clinical presentation and management].

Authors:  C Prodinger; A Diem; J W Bauer; M Laimer
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

3.  Adopting a Sustainable Community of Practice Model when Developing a Service to Support Patients with Epidermolysis Bullosa (EB): A Stakeholder-Centered Approach.

Authors:  Rosemary Joan Gowran; Avril Kennan; Siobhán Marshall; Irene Mulcahy; Sile Ní Mhaille; Sarah Beasley; Mark Devlin
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

Review 4.  Anesthetic Management of Adults With Epidermolysis Bullosa.

Authors:  Brita M Mittal; Candida L Goodnough; Erin Bushell; Sophia Turkmani-Bazzi; Kelly Sheppard
Journal:  Anesth Analg       Date:  2022-01-01       Impact factor: 6.627

Review 5.  Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.

Authors:  Jakub Tolar; John E Wagner
Journal:  Lancet       Date:  2013-10-05       Impact factor: 79.321

Review 6.  Dystrophic epidermolysis bullosa: a review.

Authors:  Satoru Shinkuma
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-26

Review 7.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Anastasiya V Kosykh; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

8.  Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database.

Authors:  Laura E Levin; Leila H Shayegan; Anne W Lucky; Kristen P Hook; Anna L Bruckner; James A Feinstein; Susan Whittier; Christine T Lauren; Elena Pope; Irene Lara-Corrales; Karen Wiss; Catherine C McCuaig; Julie Powell; Lawrence F Eichenfield; Moise L Levy; Lucia Diaz; Sharon A Glick; Amy S Paller; Harper N Price; John C Browning; Kimberly D Morel
Journal:  Pediatr Dermatol       Date:  2020-11-28       Impact factor: 1.588

9.  Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders.

Authors:  Paula Davila-Seijo; Angela Hernández-Martín; Evanina Morcillo-Makow; Raúl de Lucas; Esther Domínguez; Natividad Romero; Eva Monrós; Marta Feito; Luis Carretero; Bea Aranegui; Ignacio García-Doval
Journal:  Orphanet J Rare Dis       Date:  2013-04-22       Impact factor: 4.123

Review 10.  Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.

Authors:  May El Hachem; Giovanna Zambruno; Eva Bourdon-Lanoy; Annalisa Ciasulli; Christiane Buisson; Smail Hadj-Rabia; Andrea Diociaiuti; Carolina F Gouveia; Angela Hernández-Martín; Raul de Lucas Laguna; Mateja Dolenc-Voljč; Gianluca Tadini; Guglielmo Salvatori; Cristiana De Ranieri; Stephanie Leclerc-Mercier; Christine Bodemer
Journal:  Orphanet J Rare Dis       Date:  2014-05-20       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.